Company Filing History:
Years Active: 2025
Title: Benjamin Cossette: Innovator in Chimeric Antigen Receptor Technology
Introduction
Benjamin Cossette is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of immunotherapy, particularly in the development of chimeric antigen receptor (CAR) T cell technology. His innovative work has the potential to advance cancer treatment methodologies.
Latest Patents
Benjamin Cossette holds a patent titled "Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs." This patent features chimeric antigen receptor (CAR) ligands, methods for making them, and immunomodulatory compositions that include these CAR ligands. The disclosure also outlines compositions and methods for using these immunomodulatory compositions to stimulate the activation of CAR-expressing cells. He has 1 patent to his name.
Career Highlights
Cossette is affiliated with the Massachusetts Institute of Technology, where he continues to push the boundaries of research in immunotherapy. His work is instrumental in developing new strategies for cancer treatment, showcasing his commitment to advancing medical science.
Collaborations
He has collaborated with esteemed colleagues such as Darrell J. Irvine and Karl Dane Wittrup, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Benjamin Cossette's innovative contributions to CAR T cell technology exemplify the potential of scientific research to transform cancer therapies. His work continues to inspire advancements in the field of immunotherapy.